Source Post

Oscar Health ($OSCR) Soars Nvidia ($NVDA) Stalls

The RoseMay 20, 2026

The creator discusses Oscar Health ($OSCR) and Nvidia ($NVDA) in this segment. Oscar Health is highlighted for its recent strong earnings beat, significant revenue growth, and reaffirmation of guidance, driven by a substantial improvement in its medical loss ratio and strong member growth. Nvidia's earnings are also mentioned as a point of interest.

Linked Mentions

Tickers discussed in this post

AMZNNeutralLow ConvictionSignal-backedSecondary

Amazon is a top three position in the creator's YouTube portfolio.

GOOGLNeutralLow ConvictionSignal-backedSecondary

Google is a top three position in the creator's YouTube portfolio.

AMDBullishMedium ConvictionSignal-backedSecondary

Nvidia's focus on CPUs is expected to positively impact AMD, potentially continuing its recent stock gains.

NVDANeutralLow ConvictionResearch Only

Nvidia ($NVDA) is mentioned in the context of its recent earnings release, which is noted as having interesting implications for other companies, but no specific investment recommendation is made.

OSCRBullishHigh ConvictionSignal-backedPrimary

Oscar Health ($OSCR) is a strong buy due to its recent earnings beat, significant revenue growth, and improving medical loss ratio, indicating a path to profitability.

Linked Signals

Tracked calls opened from this post

OSCR
buy opened May 20, 2026
-13.78%